COGT Operating Expenses

Cogent Biosciences Inc · Operating Expenses

COGT logo

COGT Operating Expenses

Latest reported$386.76M
COGT TTM Operating Expenses ($34.51M → $386.76M)
High-resolution chart · PNG

COGT operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cogent Biosciences Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
386,761,000
358,548,000
331,029,000
306,447,000
298,506,000
288,468,000
275,939,000
260,433,000
244,599,000
227,297,000
208,130,000
193,647,000
170,888,000
159,658,000
147,839,000
129,734,000
112,732,000
94,169,000
75,551,000
61,367,000
94,056,000
79,566,000
70,440,000
61,678,000
22,226,000
33,103,000
44,323,000
54,438,000
54,001,000
51,427,000
45,739,000
41,933,000
38,815,000
35,822,000
34,512,000
50,384,000
45,642,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.